Literature DB >> 19696728

Malaria endemicity in an Orang Asli community in Pahang, Malaysia.

K Gurpreet1.   

Abstract

An epidemiological cross-sectional study was undertaken to determine the endemicity of malaria among the Orang Asli population of Raub, Pahang. Malaria endemicity was measured in terms of the prevalence of parasitaemia and splenomegaly. A total of 520 Orang Asli were examined. The point prevalence of malaria was 24.2% (95% CI 20.7-25.1), with Plasmodium falciparum (67.5%) being the predominant species. Children < 12 years were at least 3.7 times more likely to be parasitaemic compared to those older. The prevalence of malaria among children 2-<10 years was 38.1% (95% CI 31.6-50.0). Spleen rate among children 2-<10 years old was 22.3% (95% CI 17.1-28.3). The average enlarged spleen size was 1.2. These findings classify the study area as being mesoendemic. Malaria control activities among the Orang Asli should focus on protecting vulnerable subgroups like young children. Measuring the level of malaria endemicity at regular intervals is fundamental in evaluating the effectiveness of malaria control programs.

Entities:  

Mesh:

Year:  2009        PMID: 19696728

Source DB:  PubMed          Journal:  Trop Biomed        ISSN: 0127-5720            Impact factor:   0.623


  8 in total

1.  Opportunities and obstacles to the elimination of malaria from Peninsular Malaysia: knowledge, attitudes and practices on malaria among aboriginal and rural communities.

Authors:  Abdulelah H Al-Adhroey; Zurainee M Nor; Hesham M Al-Mekhlafi; Rohela Mahmud
Journal:  Malar J       Date:  2010-05-24       Impact factor: 2.979

Review 2.  Surveillance and response for high-risk populations: what can malaria elimination programmes learn from the experience of HIV?

Authors:  Jerry O Jacobson; Carmen Cueto; Jennifer L Smith; Jimee Hwang; Roly Gosling; Adam Bennett
Journal:  Malar J       Date:  2017-01-18       Impact factor: 2.979

3.  Malaria distribution and performance of malaria diagnostic methods in Malaysia (1980-2019): a systematic review.

Authors:  Mohd Amirul Fitri A Rahim; Mohd Bakhtiar Munajat; Zulkarnain Md Idris
Journal:  Malar J       Date:  2020-11-07       Impact factor: 2.979

4.  Perceptions and prevention practices on malaria among the indigenous Orang Asli community in Kelantan, Peninsular Malaysia.

Authors:  Mohd Bakhtiar Munajat; Mohd Amirul Fitri A Rahim; Wathiqah Wahid; Mohd Ikhwan Mukmin Seri Rakna; Paul C S Divis; Sriwipa Chuangchaiya; Inke Nadia D Lubis; Emelia Osman; Muhd Rafiq Mohd Kasri; Zulkarnain Md Idris
Journal:  Malar J       Date:  2021-04-27       Impact factor: 2.979

5.  Sero-prevalence of malaria and the knowledge, attitudes and practices relating to the prevention of malaria among indigenous people living in the central forest spine in Peninsular Malaysia: a mixed-methods study.

Authors:  Siti Fatimah Kader Maideen; Abdul Rashid; Nur Indah Ahmad; Siti Nur Afiqah Zahari; Rukman Awang Hamat
Journal:  Malar J       Date:  2022-10-03       Impact factor: 3.469

6.  Aboriginal populations and their neglected tropical diseases.

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2014-01-30

7.  Is there a risk of suburban transmission of malaria in Selangor, Malaysia?

Authors:  Kamil A Braima; Jia-Siang Sum; Amir-Ridhwan M Ghazali; Mustakiza Muslimin; John Jeffery; Wenn-Chyau Lee; Mohammed R Shaker; Alaa-Eldeen M Elamin; Ibrahim Jamaiah; Yee-Ling Lau; Mahmud Rohela; Adeeba Kamarulzaman; Frankie Sitam; Rosnida Mohd-Noh; Noraishah M Abdul-Aziz
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

8.  Increased risks of cardiovascular diseases and insulin resistance among the Orang Asli in Peninsular Malaysia.

Authors:  Tuan Azlin Tuan Abdul Aziz; Lay Kek Teh; Muhd Hanis Md Idris; Zakaria Bannur; Lydiatul Shima Ashari; Adzrool Idzwan Ismail; Aminuddin Ahmad; Kamarudzaman Md Isa; Fadzilah Mohd Nor; Thuhairah Hasrah Abdul Rahman; Syahrul Azlin Binti Shaari; Hamid Jan Jan Mohamed; Nornazliya Mohamad; Mohd Zaki Salleh
Journal:  BMC Public Health       Date:  2016-03-24       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.